EL7.AI
StocksMedium•16 November 2026•
3 min read

Virtuix Sales Rise 21% to $1.2 Million in Fiscal Second Quarter

Key Facts

1Second-quarter fiscal 2027 sales totaled $1.2 million, up 21% year over year.
2Omni One sales rose 105% to $1.1 million, while sales of legacy Omni Arena products fell by $0.3 million.
3Gross margin fell to 25% from 41% a year earlier.
4The net loss widened to $6.4 million, or $0.19 per share, compared with $1.9 million and $0.09 per share a year earlier.
5Cash and cash equivalents declined to $5.0 million on September 30, 2026, from $9.5 million on March 31, 2026.

Virtuix Holdings said on November 16 that sales totaled $1.2 million in the second quarter of its fiscal 2027, ended September 30, 2026, up 21% year over year and 55% from the previous quarter. In its filing, the company said sales rose from $1.0 million in the same period a year earlier and from $0.8 million in the first quarter of the current fiscal year. The growth reflects expanded sales of the Omni One product, which partly offset a decline in Omni Arena activity. But the improvement in revenue was not accompanied by an improvement in gross margin or net loss. The reported 12% share-price decline in an earlier account could not be confirmed, and the November 13 close preceded the results announcement and does not establish a market reaction to it.

Omni One sales rose 105% to $1.1 million, from $0.5 million a year earlier, the company said. Virtuix attributed the growth mainly to the launch of Omni One for the Quest platform in collaboration with Meta. By contrast, sales of legacy Omni Arena products and services fell by $0.3 million, limiting the new product's contribution to total sales. The company said orders for Omni One units were 3.3 times their level a year earlier after the product launched in June 2026. It added that it became an official Meta distributor, introduced bundles featuring the Quest 3 and Quest 3S headsets, and expanded its library of compatible or upcoming titles to more than 75.

In enterprise sales, orders for Omni One Enterprise increased 45% year over year in the quarter. New orders included the first order from Figure AI and repeat orders from Tesla for its Optimus humanoid robot program, according to the company filing. Despite revenue growth, gross margin fell to 25% from 41% in the same period a year earlier. Virtuix said the decline reflected a shift in the sales mix toward Omni One, compared with the higher-margin Omni Arena products and services. The shift puts order and sales growth alongside the challenge of maintaining margins as revenue sources change.

The net loss widened to $6.4 million, or $0.19 per share, compared with a loss of $1.9 million, or $0.09 per share, a year earlier. It narrowed, however, from $7.2 million in the first quarter of fiscal 2027. Operating expenses were $5.1 million, compared with $1.9 million in the same period. The company cited higher non-cash stock-based compensation, marketing spending to expand sales for the 2026 holiday season, and administrative, professional and insurance costs related to operating as a public company. It also recorded net other expenses of $1.5 million, compared with $0.3 million a year earlier, attributing the increase mainly to non-cash debt-related amortization and warrant adjustments, partly offset by non-cash fair-value gains on financial instruments.

On liquidity, cash and cash equivalents totaled $5.0 million on September 30, 2026, compared with $9.5 million on March 31 of the same year. The chief financial officer said the company expects cash burn to decline as revenue grows and cost-cutting measures are implemented. The chief executive said management priorities include converting growing demand into revenue, expanding higher-margin enterprise opportunities, pursuing larger defense programs and reducing operating costs in pursuit of profitability. In its expansion into therapeutic applications, the company said the LB Foundation joined an autism treatment initiative with Serica Therapeutics, and that a multi-site trial is scheduled to begin in early 2027. Virtuix had set November 16 at 8:30 a.m. Eastern Time for a results discussion call and question-and-answer session.

Open on chart